Updated ISPAD guidelines on pathophysiology, diagnosis, clinical course and management of Cystic-fibrosis Related Diabetes. These talk about the role of glucose tolerance tests, hemoglobin A1c, continuous…
PES Drugs and Therapeutics Committee presents a statement on the Risk of Prolonged QT Interval with Gonadotropin Releasing Hormone Agonists.
A review of the current literature pertaining to the endocrine concerns of Prader Willi Syndrome and current recommendations for screening and management of these conditions.
